止咳糖浆市场规模、份额和增长分析（按产品、年龄组、分布和地区）- 行业预测，2025-2032 年

2023 年全球止咳糖浆市场规模价值 52 亿美元，预计将从 2024 年的 54.1 亿美元增长到 2032 年的 74 亿美元，预测期内（2025-2032 年）的复合年增长率为 4.0%。

由于各大製药公司对创新配方研发的大量投资，全球止咳糖浆市场呈现良好的成长轨迹。消费者对及时处理咳嗽相关问题的认识不断提高，进一步推动了市场扩张。公司正在利用策略联盟、产品发布和有针对性的行销努力来提高其竞争地位。网上购物平台的便利性也增加了市场可近性，使消费者更容易探索多样化的产品选择。从区域来看，所有地区的需求都在显着增长，尤其是医疗基础设施不断发展、可支配收入不断提高的新兴市场。此外，向草药和天然替代品的转变正在重塑市场动态。儘管存在监管挑战和对滥用的担忧，市场前景仍然乐观。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 次要和资料资料
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024 年）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析

止咳糖浆市场规模（按产品和复合年增长率） (2025-2032)

• 市场概况
• 祛痰药
• 止咳药
• 抗组织胺药
• 伴随用药

止咳糖浆市场规模（依年龄层划分）及复合年增长率（2025-2032 年）

• 市场概况
• 孩子们
• 成人

止咳糖浆市场规模（按分销管道和复合年增长率） (2025-2032)

• 市场概况
• 零售
• 药局
• 医院
• 其他的

止咳糖浆市场规模（按地区）及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲国家
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前 5 家公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采用的策略
• 近期市场趋势
• 公司市场占有率分析（2024 年）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分析市场份额
  • 收益与前一年同期比较（2022-2024 年）

主要企业简介

• Johnson & Johnson（USA）
• Pfizer Inc.（USA）
• GlaxoSmithKline plc（UK）
• Sanofi SA（France）
• Bayer AG（Germany）
• Reckitt Benckiser Group plc（UK）
• Procter & Gamble（USA）
• Prestige Consumer Healthcare Inc.（USA）
• Church & Dwight Co., Inc.（USA）
• Dabur India Ltd.（India）
• Himalaya Wellness Company（India）
• Cipla Ltd.（India）
• Sun Pharmaceutical Industries Ltd.（India）
• Mankind Pharma Ltd.（India）
• Perrigo Company plc（Ireland）
• Teva Pharmaceutical Industries Ltd.（Israel）
• Mylan NV（USA）
• Perrigo Company plc（Ireland）
• Valeant Pharmaceuticals International, Inc.（Canada）
• Medtech Products Inc.（USA）

结论和建议

Global Cough Syrup Market size was valued at USD 5.2 billion in 2023 and is poised to grow from USD 5.41 billion in 2024 to USD 7.4 billion by 2032, growing at a CAGR of 4.0% during the forecast period (2025-2032).

The Global Cough Syrup Market is on a promising growth trajectory, driven by significant investments from major pharmaceutical companies in research and development of innovative formulations. Increased consumer awareness regarding the prompt management of cough-related issues further fuels market expansion. Companies are leveraging strategic partnerships, product launches, and targeted marketing efforts to enhance their competitive positions. The convenience of online purchasing platforms also boosts market accessibility, enabling consumers to explore diverse product options easily. Geographically, all regions are experiencing notable increases in demand, especially in emerging economies with advancing healthcare infrastructure and rising disposable incomes. Additionally, the shift towards herbal and natural alternatives is reshaping market dynamics. Despite regulatory challenges and concerns over misuse, the market outlook remains positive.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cough Syrup market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cough Syrup Market Segmental Analysis

Global Cough Syrup Market is segmented by Product, Age Group, Distribution and region. Based on Product, the market is segmented into Expectorants, Cough Suppressants, Antihistamines and Combination Medication. Based on Age Group, the market is segmented into Pediatric and Adult. Based on Distribution, the market is segmented into Retail, Pharmacy, Hospital and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Cough Syrup Market

A significant factor fueling the global cough syrup market is the rising incidence of respiratory disorders across the globe. The surge in respiratory ailments can be attributed to several factors, including escalating air pollution levels, fluctuating weather patterns, and the widespread transmission of viral infections. These elements collectively result in a higher occurrence of cough and cold-related symptoms among populations, consequently driving demand for cough syrups as a reliable treatment option. As more individuals seek relief from these common yet bothersome ailments, the cough syrup market is expected to experience continued growth and expansion.

Restraints in the Global Cough Syrup Market

One of the major constraints facing the global cough syrup market is the stringent regulations aimed at preventing the misuse of these products, especially those that contain codeine or other addictive components. Authorities and governments worldwide are increasingly enforcing strict controls and imposing prescription requirements to combat potential abuse and misuse of cough syrups. These regulations are intended to safeguard public health but can inadvertently restrict access to these medications for legitimate consumers. Consequently, such limitations may hinder the overall growth potential of the cough syrup market, as manufacturers must navigate a complex landscape of compliance and risk management.

Market Trends of the Global Cough Syrup Market

The Global Cough Syrup market is witnessing a significant shift towards natural and plant-based formulations, driven by heightened consumer awareness regarding health and wellness. As more individuals prioritize holistic health solutions, there is a marked increase in demand for cough syrups containing herbal extracts and other natural ingredients, which are perceived as safer alternatives to synthetic products. This trend reflects a growing consumer preference for sustainable and effective healthcare options, with an emphasis on the efficacy of natural remedies in alleviating cough and cold symptoms. Consequently, manufacturers are focusing on developing innovative, eco-friendly cough syrup products to cater to this evolving consumer landscape.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Cough Syrup Market Size by Product & CAGR (2025-2032)

• Market Overview
• Expectorants
• Cough Suppressants
• Antihistamines
• Combination Medication

Global Cough Syrup Market Size by Age Group & CAGR (2025-2032)

• Market Overview
• Pediatric
• Adult

Global Cough Syrup Market Size by Distribution & CAGR (2025-2032)

• Market Overview
• Retail
• Pharmacy
• Hospital
• Others

Global Cough Syrup Market Size & CAGR (2025-2032)

• North America (Product, Age Group, Distribution)
  • US
  • Canada
• Europe (Product, Age Group, Distribution)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Age Group, Distribution)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Age Group, Distribution)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Age Group, Distribution)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Johnson & Johnson (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi S.A. (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Reckitt Benckiser Group plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Procter & Gamble (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Prestige Consumer Healthcare Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Church & Dwight Co., Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dabur India Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Himalaya Wellness Company (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cipla Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sun Pharmaceutical Industries Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mankind Pharma Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Perrigo Company plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceutical Industries Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mylan N.V. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Perrigo Company plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Valeant Pharmaceuticals International, Inc. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtech Products Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations